Clinical Trial Update: "An Intermediate Size Patient Population Expanded Access Protocol to Evaluate the Safety and Efficacy of Allogeneic HB-adMSCs (Hope Biosciences - Adipose Derived Mesenchymal Stem Cells) for the Treatment of Multiple System Atrophy."

View source ↗

Summary

Clinical trial update describing an expanded access protocol to evaluate the safety and efficacy of allogeneic HB-adMSCs for the treatment of Multiple System At…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple System Atrophy

Drugs mentioned

• HB-adMSCs (autologous adipose-derived mesenchymal stem cells)

Snippet

Sponsor: Hope Biosciences Research Foundation | Conditions: Multiple System Atrophy | Status: AVAILABLE